|04 Intervention and Control|
As evident in the COVID-19 pandemic, a substantial challenge in managing epidemics is the duration of the application of non-pharmaceutical interventions (NPIs), especially those that disrupt “normal” societal organization and function such as social distancing. These measures quickly become infeasible as pandemic fatigue builds.
- As pharmaceutical interventions (PIs) such as vaccines, antiviral, or antimicrobial therapies become available, their gradual deployment, concurrently with a potential weakening of the NPIs, raises organizational challenges; uncertainty about vaccine or antimicrobial efficacy or potential for vaccine waning further complicates the issue, as do potential viral evolutions in response to the use of therapeutic tools. COVID-19 has highlighted the need for novel approaches using a One Health (OH) and the following projects aim to do just that.